VP

Ved Prakash

Active Director Director DIN 10467144
DIN 10467144 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ved Prakash

Data last updated:

Ved Prakash is a Director at Emrgin Health Care Private Limited (since 2025) and Director at Yesclone Pharmaceuticals Private Limited (since 2024). The companies operate in Pharma.

DIN 10467144
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emrgin Health Care Private Limited U46497UP2025PTC222166
Director24 Apr 20252025Active
Director16 Jan 20242024Active

Directorship timeline

Open interactive timeline →
Emrgin Health Care Private Limited
Yesclone Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ved Prakash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ved Prakash

Ved Prakash currently holds 2 directorships: Emrgin Health Care Private Limited (Director, since 24 Apr 2025); Yesclone Pharmaceuticals Private Limited (Director, since 16 Jan 2024).

Ved Prakash was first appointed on 16 Jan 2024 as Director at Yesclone Pharmaceuticals Private Limited. The most recent appointment on record is 24 Apr 2025 at Emrgin Health Care Private Limited.

The current boards of Ved Prakash's companies include Kishori Lal Shukla (Emrgin Health Care Private Limited), Anikesh Chandra (Yesclone Pharmaceuticals Private Limited), Vikash Tiwari (Yesclone Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available